Hospitalization Trends in Patients With Psoriasis
The longitudinal trends of psoriasis hospitalizations after the introduction of biologic agents is tracked.
The longitudinal trends of psoriasis hospitalizations after the introduction of biologic agents is tracked.
Researchers assessed the association between initiation with IL-17 inhibitors and risk for inflammatory bowel disease in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis
Researchers assessed the role of ultrasonography in the evaluation of disease activity in patients with psoriatic arthritis with concomitant fibromyalgia syndrome.
Using a population-based cohort, researchers assessed the effects of gout on risk for cardiovascular disease in patients with psoriasis.
Secukinumab vs adalimumab for treatment in patients with concomitant plaque psoriasis and active psoriatic arthritis during 52 weeks is reported.
The objective of the study was to determine the risk of developing psoriatic arthritis in patients with psoriasis receiving certain treatments, such as biologics.
Researchers studied the effect of apremilast on body weight and composition, glucose homeostasis, lipid profiles, and vascular function in psoriatic disease.
Psoriasis and psoriatic arthritis have been associated with the underreporting and undertreatment of pain. To provide adequate care and management of pain in psoriatic disease, a multidisciplinary approach is required.
Psoriasis may be another risk factor for infectious complications in patients receiving dialysis, according to investigators.
Researchers assessed sex differences in disease activity parameters and health-related quality of life in psoriatic arthritis.